Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
2007-06-26
2007-06-26
Salimi, Ali R. (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
C530S300000, C435S069100
Reexamination Certificate
active
10744964
ABSTRACT:
By virtue of the present invention, there is provided methods and compositions for interfering with the proliferation of cells infected and/or transformed by papillomaviruses. The processes and compositions of this invention may be used to treat any mammal, including humans. According to this invention, mammals are treated by the pharmaceutically acceptable administration of an E2 peptidomimetic to reduce the symptoms of the specific papillomavirus-associated disease, or to prevent their recurrence.
REFERENCES:
patent: 5656599 (1997-08-01), Androphy et al.
patent: 5821048 (1998-10-01), Howley et al.
patent: 5932412 (1999-08-01), Dillner et al.
patent: 6399075 (2002-06-01), Howley et al.
patent: 6673354 (2004-01-01), Howley et al.
patent: 2003/0194698 (2003-10-01), White et al.
patent: WO 92/11290 (1992-07-01), None
patent: WO 96/41018 (1996-12-01), None
Derossi et al. The Journal of Biological Chemistry, 1996, vol. 27, No. 30, pp. 18188-18193.
Abroi, A. et al.Transcriptional and replicational activation functions in the papillomavirus type 1 E2 protein are encoded by different structural determinants, J. VIROL 70: 6169-6179 (1996).
Breiding, D.E. et al,Genetic analysis of the bovine papillomavirus E2 transcriptional activation domain, VIROLOGY 221: 34-43 (1996).
Brokaw, J.L.,Amino acids critical for the functions of the bovine papillomavirus type 1 transactivator, J. VIROL. 70: 23-29 (1996).
Ferguson, M.F.,Genetic analysis of the activation domain of bovine papillomavirus protein E2: its role in transcription and replication, J. VIROL. 70: 4193-4199 (1996).
Grossel, M.J.,Transcriptional activation function is not required for stimulation of DNA replication by bovine papillomavirus type 1 E2, J. VIROL. 70: 7264-7269 (1996).
Kuo, S.,Cell-free replication of humanpapillomavirus DNA with homologous viral E1 and E2 proteins and human cell extracts, J. Biol. Chem. 269: 24058-24065 (1994).
Liu, J.,The functions of human papillomavirus type 11 E1, E2, and E2C proteins in cell-free DNA replication, J. Biol. Chem. 270: 27283-27291 (1995).
Lusky, M.,Cooperative assembly of the bovine papilloma virus E1 and E2 proteins on the replication origin requires an intact E2 binding site, J. Biol. Chem. 268: 15795-15803 (1993).
Lusky, M.,The bovine papillomavirus E2 protein modulates the assembly of but is not stnbly maintained in a replication-competent multimeric E1-replication origin complex, Proc. Natl. Acad. Sci. USA 91: 8895-8899 (1994).
McBride, A.A.,The carboxy-terminal domain shared by the bovine papillomavirus E2 transactivator and repressor protein contains a specific DNA binding activity, EMBO J. 7: 533-539 (1988).
McBride, A.A.,E2 polypeptides encoded by bovine papillomavirus type I form dimers through the common carboxyl-terminal domain: transactivation is mediated by the conserved amino-terminal domain, Pros. Natl. Acad. Sci. USA 86: 510-514 (1989).
Mohr, I. Et al,Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator, SCIENCE 250: 1694-1699 (1990).
Sedman, J. et al,Cooperative interaction between the initiator E1 and the transcriptional activator E2 is required for replication of bovine papillomavirus in vivo and in vitro, EMBO J. 14: 6218-6228 (1995).
Sedman, T.,Binding of the E1 and E2 proteins to the origin of replication of bovine papillomavirus, J. VIROL 71: 2887-2896 (1997).
Seo, Y.,Bovine pappiloma virus(BPV)-encoded E2 protein enhances binding of E1 protein ot the BPV replication origin, Proc. Natl. Acad. Sci. USA 90: 2865-2869 (1993).
Sverdrup, F.,Replication of human papillomavirus(HPV)DNAs supported by the HPV type 18 E1 and E2 proteins, J. VIROL. 68: 505-509 (1994).
Ustav, M.,Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames, EMBO J. 10: 449-457 (1991).
Winokur, P.L.,Separation of the transcriptional activation and replication functions of the bovine papillomavirus-1 E2 protein, EMBO. J. 11: 4111-4118 (1992).
Yang, L.,Activation of BPV-1 replication in vitro by the transcription factor E2, Nature 353: 628-632 (1991).
Yasugi, T.,Mappingand characterization of the interaction domains of the human papillomavirus type 16 E1 and E2 proteins, J. VIROL. 71: 891-899 (1997).
Yasugi, T.,Two classes of human papillomavirus type 16 E1 mutants suggest pleitropic conformational constraints affecting E1 multimerization, E2 interaction, and interaction with cellular proteins, J. VIROL. 71: 5942-5951 (1997).
Zou, N.,The carboxyl-terminal region of the human papillomavirus type 16 E1 protein determindes E2 protein specificity during DNA replication, J. VIROL. 72: 3436-3441 (1998).
Benson John
Howley Peter M.
Kasukawa Hiroaki
Foley & Hoag LLP
President and Fellows of Harvard College
Salimi Ali R.
LandOfFree
Compositions and methods for treating... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for treating..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for treating... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3836193